Research Progress on BMF Proapoptosis
DOI:
Author:
Affiliation:

Department of Pathophysiology,Institute of Basic Medical Science,PLA General Hospital

Clc Number:

Fund Project:

This work was supported by a grant from The National Natural Scientific Foundation of China (81470437, 81270187, 81170139)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Bcl-2-modifying factor (BMF) is a member of the BH3-only family of proapoptotic proteins. Under physiological conditions, BMF is sequestered to the cytoskeleton by association with dynein light chains 2, which prevents BMF to induce cell apoptosis. Some damage stimuli can release BMF from the cytoskeleton, allowing it to translocate to mitochondria and initiate mitochondrial apoptosis pathway. The proapoptotic activity of BMF is regulated at the transcriptional, translational and posttranslational levels. The upregulated and overexpressed BMF is also located predominantly in mitochondrial membranes that is consistent with its ability to induce cell death. Therefore, BMF is a powerful inducer of apoptosis.

    Reference
    Related
    Cited by
Get Citation

LI Yu-Zhen. Research Progress on BMF Proapoptosis[J]. Progress in Biochemistry and Biophysics,2017,44(9):751-756

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 12,2016
  • Revised:July 01,2017
  • Accepted:August 14,2017
  • Online: September 21,2017
  • Published: September 20,2017